ArticleFrontiers in immunology2022

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma.

Jin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.